Oxular
Dan Sea has over 20 years of work experience in the clinical operations field. Dan began their career in 1997 at ICON plc as a Quality Assurance Auditor, Clinical Research Associate, and Clinical Research Assistant. In 2000, they moved to Cellegy Pharmaceuticals Inc as a Clinical Research Associate III (Project Manager). In 2001, they worked at Nelson Professional Sales Inc as a Janssen ElderCare Contract Sales Representative. From 2002 to 2016, they worked at Shire Pharmaceuticals in various roles, including Associate Director Clinical Programs, Senior Clinical Scientist II, Clinical Program Manager, and Associate Clinical Operations Manager. From 2016 to 2019, they were Associate Director Clinical Operations at Teva Pharmaceuticals. Since 2019, they have been Director Clinical Operations at Gyroscope Therapeutics. In 2022, they will move to Oxular as Senior Director Clinical Operations.
Dan Sea attended Virginia Wesleyan University from 1993 to 1997, where they earned a Bachelor of Arts (B.A.) degree in Biology/Biological Sciences, General.
This person is not in any offices
Oxular
Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye.